The purpose of the Immunocytochemistry and Islet Isolation Core Facility is to fold: 1) to make available to the team of the Project a variety of immunocytochemical techniques for the analysis of cells and tissues with state of the art technology; 2) to supply the individual investigators with freshly isolated pancreatic islets from ice. The facility will offer technical and scientific expertise for immunocytochemical studies using conventional and confocal light microscopy as well as provide services in cryomicrotomy and immuncytochemistry for the histological analysis of tissues and cell lines from normal and trangenic animals. These techniques will be applied to the study of proteins such as MHC molecules, T cell receptors, cytokines, and beta-cell utoantigens, including GAD, insulin and ICA512. Routine isolation of freshly pancreatic islet cells from NOD and transgenic mice will be required for generating and maintaining islet- specific T cell clones. A centralized facility has the advantage of assuring that islets for the different projects are prepared using standardized and up-to-date procedures.

Project Start
2001-12-01
Project End
2003-11-30
Budget Start
Budget End
Support Year
5
Fiscal Year
2002
Total Cost
$180,000
Indirect Cost
Name
Yale University
Department
Type
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Bonner, Samantha M; Pietropaolo, Susan L; Fan, Yong et al. (2012) Sequence variation in promoter of Ica1 gene, which encodes protein implicated in type 1 diabetes, causes transcription factor autoimmune regulator (AIRE) to increase its binding and down-regulate expression. J Biol Chem 287:17882-93
Kim, Sunshin; Millet, Isabelle; Kim, Hun Sik et al. (2007) NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci U S A 104:1913-8
Millet, I; Wong, F S; Gurr, W et al. (2006) Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes. J Autoimmun 26:7-15
Du, Wei; Wong, F Susan; Li, Ming O et al. (2006) TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest 116:1360-70
Li, Ming O; Wan, Yisong Y; Sanjabi, Shomyseh et al. (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99-146
Kriegel, Martin A; Li, Ming O; Sanjabi, Shomyseh et al. (2006) Transforming growth factor-beta: recent advances on its role in immune tolerance. Curr Rheumatol Rep 8:138-44
Wen, L; Wong, F S (2005) How can the innate immune system influence autoimmunity in type 1 diabetes and other autoimmune disorders? Crit Rev Immunol 25:225-50
Wong, F Susan; Wen, Li; Tang, Michelle et al. (2004) Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53:2581-7
Eshima, Koji; Mora, Conchi; Wong, F Susan et al. (2003) A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse. Int Immunol 15:351-7
Rajagopalan, Govindarajan; Kudva, Yogish C; Flavell, Richard A et al. (2003) Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes 52:342-7

Showing the most recent 10 out of 27 publications